In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates
Open Access
- 1 May 2004
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (5) , 1912-1915
- https://doi.org/10.1128/aac.48.5.1912-1915.2004
Abstract
In this study, we evaluated the in vitro activity of anidulafungin against selected mold isolates. Anidulafungin showed promising activity against Bipolaris spicifera , Exophiala jeanselmei , Fonsecaea pedrosoi , Madurella mycetomatis , Penicillium marneffei , Phialophora verrucosa , Pseudallescheria boydii , Sporothrix schenckii , and Wangiella dermatitidis.Keywords
This publication has 29 references indexed in Scilit:
- Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantationMedical and Pediatric Oncology, 2003
- Successsful Voriconazole Treatment of Disseminated Fusarium Infection in an Immunocompromised PatientClinical Infectious Diseases, 2003
- Voriconazole in the Treatment of Invasive Mold Infections in Transplant RecipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- CaspofunginClinical Infectious Diseases, 2003
- In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus sppDiagnostic Microbiology and Infectious Disease, 2003
- CaspofunginDrugs, 2003
- Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- The Spectrum of Non-Candida Fungal Infections following Bone Marrow TransplantationMedicine, 1993